PTC Therapeutics (P91) Revenue

1 Followers

PTC Therapeutics Revenue

PTC Therapeutics had a revenue of 360.52M in the quarter ending Jun 30, 2026, with 32.28%. This bring the company's revenue in the last twelve months to 1.01B, Decreased 21.96%. In the fiscal year ending Dec 31, 2025, PTC Therapeutics had annual revenue of 1.73B with 114.51% growth.

Revenue (ttm)

1.01B

Revenue Growth

―

P/S Ratio

2.65

Revenue/Employee

CHF1,746,372

Employees

991

Market Cap

CHF4.59B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	1.73B	923.88M	+114.51%
Dec 31, 2024	806.78M	-131.04M	-13.97%
Dec 31, 2023	937.82M	239.02M	+34.20%
Dec 31, 2022	698.80M	160.21M	+29.75%
Dec 31, 2021	538.59M	157.83M	+41.45%
Dec 31, 2020	380.77M	73.79M	+24.04%
Dec 31, 2019	306.98M	42.25M	+15.96%
Dec 31, 2018	264.73M	70.34M	+36.19%
Dec 31, 2017	194.39M	―	―